Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impairment of Social-Related Quality of Life in COVID-19 Pneumonia Survivors: A Prospective Longitudinal Study.
Ando T, Shimada S, Sugihara J, Takayama K, Kobayashi M, Miyashita Y, Ito T, Okayasu K, Tsuyuki S, Ohba T, Doi M, Saito H, Fujie T, Chiaki T, Nakagawa A, Anzai T, Takahashi K, Shibata S, Tateishi T, Miyazaki Y. Ando T, et al. Among authors: tsuyuki s. J Clin Med. 2023 Dec 12;12(24):7640. doi: 10.3390/jcm12247640. J Clin Med. 2023. PMID: 38137709 Free PMC article.
BRCA2 reversion mutation confers resistance to olaparib in breast cancer.
Yamamoto S, Kawashima K, Fujiwara Y, Adachi S, Narui K, Hosaka C, Takahashi R, Tsuyuki S, Sugimori M, Tanoshima M, Sasamoto M, Oshi M, Yamada A, Kunisaki C, Endo I. Yamamoto S, et al. Among authors: tsuyuki s. Clin Case Rep. 2023 Jun 23;11(6):e7537. doi: 10.1002/ccr3.7537. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37361653 Free PMC article.
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study.
Kikawa Y, Kotake T, Tsuyuki S, Kang Y, Takahara S, Fujimoto Y, Yamashiro H, Yoshibayashi H, Takada M, Yasuoka R, Nakatsukasa K, Yamagami K, Suwa H, Okuno T, Nakayama I, Kato T, Ogura N, Moriguchi Y, Ishiguro H, Kagimura T, Taguchi T, Sugie T, Toi M. Kikawa Y, et al. Among authors: tsuyuki s. Breast Cancer. 2022 Sep;29(5):796-807. doi: 10.1007/s12282-022-01357-x. Epub 2022 Apr 23. Breast Cancer. 2022. PMID: 35460066
Evaluation of a novel medical device for pegfilgrastim administration.
Aruga T, Doihara H, Yanagita Y, Ishida T, Yamashita T, Uehara K, Taira T, Tsurutani J, Takeshita T, Tsuyuki S, Kaneko K, Ohtake T, Yamaguchi Y, Hara Y, Saji S. Aruga T, et al. Among authors: tsuyuki s. Cancer Sci. 2022 May;113(5):1763-1770. doi: 10.1111/cas.15335. Epub 2022 Mar 29. Cancer Sci. 2022. PMID: 35293085 Free PMC article.
The Origin of Epithelium with Low-Grade Atypia in Early Gastric Cancer.
Yamada H, Kaneko H, Kuwashima H, Sugimori M, Tsuyuki S, Sanga K, Irie K, Sasaki T, Kondo M, Miyake A, Maeda S. Yamada H, et al. Among authors: tsuyuki s. Digestion. 2022;103(3):217-223. doi: 10.1159/000521875. Epub 2022 Feb 16. Digestion. 2022. PMID: 35172301 Free PMC article.
63 results